Scientific article
OA Policy
English

Adenosine diphosphate-induced platelet aggregation is associated with P2Y12 gene sequence variations in healthy subjects

Published inCirculation, vol. 108, no. 8, p. 989-995
Publication date2003
Abstract

The adenosine diphosphate (ADP) receptor P2Y12 plays a pivotal role in platelet aggregation, as demonstrated by the benefit conferred by its blockade in patients with cardiovascular disease. Some studies have shown interindividual differences in ADP-induced platelet aggregation responses ex vivo, but the mechanisms underlying this variability are unknown.

Keywords
  • Adenosine Diphosphate/pharmacology
  • Adolescent
  • Adult
  • Alleles
  • Base Sequence
  • Blood Platelets/drug effects/metabolism
  • Cyclic AMP/metabolism
  • Dose-Response Relationship, Drug
  • Drug Resistance/genetics
  • Genetic Testing
  • Genetic Variation
  • Haplotypes
  • Heterozygote
  • Humans
  • Integrin beta3/genetics
  • Male
  • Membrane Proteins
  • Molecular Sequence Data
  • Platelet Aggregation/drug effects/genetics
  • Polymorphism, Genetic
  • Receptors, Purinergic P2/genetics
  • Receptors, Purinergic P2Y12
  • Reference Values
Affiliation entities Not a UNIGE publication
Funding
  • Swiss National Science Foundation - 81LA-63350
Citation (ISO format)
FONTANA, Pierre et al. Adenosine diphosphate-induced platelet aggregation is associated with P2Y12 gene sequence variations in healthy subjects. In: Circulation, 2003, vol. 108, n° 8, p. 989–995. doi: 10.1161/01.CIR.0000085073.69189.88
Main files (1)
Article (Accepted version)
accessLevelPublic
Identifiers
Journal ISSN0009-7322
342views
215downloads

Technical informations

Creation05/03/2020 10:59:00
First validation05/03/2020 10:59:00
Update03/02/2025 11:21:08
Status update03/02/2025 11:21:08
Last indexation03/02/2025 11:29:22
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack